Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Investor World Review.
Press releases published on May 14, 2025

Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that new data on the company’s PK …

Hola Prime and Pro Basketball Player Karl-Anthony Towns Team up for 'Speed is Success' Campaign, Redefining Prop Trading
NEW YORK, NY, May 14, 2025 (GLOBE NEWSWIRE) -- Hola Prime, a leading global proprietary trading firm, is proud to announce Basketball Champion, Karl Anthony Towns as its first-ever brand ambassador. This partnership marks a significant moment in Hola …

Bosch focuses on growth in United States
Detroit, May 14, 2025 (GLOBE NEWSWIRE) -- “By 2030, our ambition is for the North American region to represent 20 percent of the company’s global sales, with the U.S. representing the majority,” Bosch Chairman Stefan Hartung. Bosch has invested more than $ …

Bitget Wallet Launches In-App Crypto Shopping Across 300+ Global Brands
SAN SALVADOR, El Salvador, May 14, 2025 (GLOBE NEWSWIRE) -- Bitget Wallet, the leading non-custodial crypto wallet, has launched "Shop with Crypto," a new in-app marketplace enabling users to spend cryptocurrencies directly on goods and services. The …

Bitget Wallet Joins Consensus Toronto to Showcase Innovation and Growth
TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Bitget Wallet, the leading non-custodial Web3 wallet, will participate in Consensus Toronto, one of Web3's most anticipated events, taking place from 14 May to 16 May, 2025. As the Web3 landscape matures, Bitget …

Editas Medicine to Present in vivo HSC Delivery, Editing, and Biodistribution Data at the European Hematology Association 2025 Congress in June
Preclinical studies achieved therapeutically relevant gene editing levels of the HBG1/2 promoter …

Fiera Capital Corporation announces $60 million bought deal offering of 7.75% Senior Subordinated Unsecured Debentures
MONTREAL, May 14, 2025 (GLOBE NEWSWIRE) -- Fiera Capital Corporation ("Fiera Capital" or the "Company") (TSX: FSZ) is pleased to announce that it has entered into an agreement with Scotiabank, CIBC Capital Markets, Desjardins Capital Markets and RBC …

Extended Detection and Response Market Surges to $8.8 billion - Led by Trend Micro (Japan), Microsoft (US), Bitdefender (Romania)
Delray Beach, FL, May 14, 2025 (GLOBE NEWSWIRE) -- According to a research report Extended Detection and Response Market size is projected to grow from USD 1.7 billion in 2023 to USD 8.8 billion by 2028 at a Compound Annual Growth Rate (CAGR) of 38.4% …

Beam Therapeutics to Highlight New Data from BEAM-101 Program in Sickle Cell Disease at European Hematology Association (EHA) 2025 Congress
Presentation to Include Updated Data from 17 Sickle Cell Disease Patients in the Ongoing BEACON Phase 1/2 Clinical Trial Evaluating Safety and Efficacy of BEAM-101 Beam to Host Investor Webcast on Friday, June 13, 2025, at 4:00 p.m. ET CAMBRIDGE, Mass., …

Primech Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
SINGAPORE, May 14, 2025 (GLOBE NEWSWIRE) -- Primech Holdings Limited ("Primech" or the "Company") (Nasdaq: PMEC), an established technology-driven facility services provider in the public and private sectors operating mainly in Singapore, today announced …

Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference
Salt Lake City, Utah, May 14, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that …

Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress
LONDON, May 14, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces the online publication of …

Syndax Announces Data Presentations at EHA 2025 Showcasing Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr)
– Revumenib abstracts highlight compelling results in acute leukemia across the frontline and R/R setting and multiple genetic populations, including mNPM1, KMT2Ar, and NUP98r – – Axatilimab abstracts highlight the robust responses observed in different …

Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701
Preclinical data highlight improved potency vs. asciminib across multiple clinically relevant variants of BCR-ABL including difficult-to-treat resistance mutations Early dose-escalation data from Phase 1 CARDINAL study of TERN-701 in CML patients showed …

Bitget Wallet and Reserve Launch Onchain Index Fund
SAN SALVADOR, El Salvador, May 14, 2025 (GLOBE NEWSWIRE) -- Bitget Wallet, the leading non-custodial crypto wallet, has integrated Reserve's Decentralized Token Folios (DTFs), introducing a new onchain index fund experience to retail crypto users. DTFs …

Autonomix CEO Brad Hauser to Present at Virtual Investor’s Closing Bell Event
Live webcast followed by an interactive Q…

Volatus Aerospace Inc. Completes Shares-for-Debt Settlement of Unsecured Convertible Debentures
/ NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV: FLT) (OTCQX: TAKOF) (Frankfurt: ABB) ("Volatus" or the “Company"), a leader in …

Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call
LITTLETON, Colo., May 14, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary …

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform
New Proprietary Target Discovery and Validation Platform Integrates Multiomics, Contingent AI, Phenoclustering, and CRISPR Screens to Accelerate Drug Discovery LOS ANGELES, May 14, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), an AI-driven …

Gas Engine Market Size to Reach $8.09 billion, Globally, by 2031 at 6.4% CAGR: The Insight Partners
US …